CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. VER. 2025;8(13s):155-161. doi:10.64149/